Chief Strategy Officer
Tue, May 26, 2026
May 26
1,858 shares @ $8.20
Decreased holdings by -0.60%
6th largest trade (out of 16)
Tax Sell-to-Cover
“Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2026. The sales do not represent a discre”Form 4 footnote
Trade made by an officer
Automatic sale to cover taxes on a vest — not a discretionary trade
Price 23% below 200-day moving average
Small Cap stock — insider trades carry more weight